Recent controversies over prescription medicines may result in a slower pace in switching drugs to over-the-counter status, supermarket pharmacy executives told SN. Because of the increased scrutiny given drugs in the COX-2 class of nonsteroidal anti-inflammatory drugs, such as Vioxx, Celebrex and Bextra, the U.S. Food and Drug Administration is likely to be more careful in approving OTC switches. For example, the anti-cholesterol drugs known as statins, although long mentioned as ...
REGISTER TO VIEW THIS ARTICLE - Register for a Free Account
Why Register for FREE?
Registering for content on Supermarket News will give you INSTANT access to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’s FREE, easy and quick. What are you waiting for! In addition you will also receive a complimentary copy of SN's salary survey sent to you by email.
Attention Paid Print Subscribers: While you have already been granted free access to SN we ask that you register now. We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.